What should be our integrated strategy for China to enable global innovation and revenue growth?

China represents a new frontier for the future of healthcare companies, from pharmaceuticals to digital technologies, representing a unique opportunity to experiment with traditional interests, solutions and business models.

Our client, a world-leading pharmaceutical company, wanted to develop a strategic position in China to tap into the value locally, and transfer that value globally.

We worked closely with broad senior stakeholders across functions and business divisions, contributing to deliverables and conversations at the C-Suite level. The strategy brought together innovation, data, reputation and partnering to create unique and sustainable positioning.